Novartis Oncology Financial Analyst Salaries in Baltimore, MD | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Financial Analyst Salaries in Baltimore, MD

The average Novartis Oncology Financial Analyst in Baltimore, MD earns an estimated $91,236 annually, which includes an estimated base salary of $84,992 with a $6,244 bonus. Novartis Oncology's Financial Analyst compensation is $3,860 more than the US average for a Financial Analyst. Financial Analyst salaries at Novartis Oncology in Baltimore, MD can range from $55,000 - $123,500.

In Baltimore, MD, The Finance Department at Novartis Oncology earns $7,429 more on average than the Operations Department.

Last updated 3 years ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$91,236
Average Compensation
$84,992
avg. base
$6,244
avg. bonus

Financial Analyst Salaries at Novartis Oncology

In Baltimore, MD, Financial Analysts earn $2,083 more than Financial Analysts, and $27,665 less than Accounting Managers.

Accounting Manager
$119k*
Financial Analyst
$89k*
Business Analyst
$89k*
Senior Accountant
$78k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Baltimore, MD, The Finance Department averages $7,429 more than the Operations Department, and $11,203 less than the Business Development Department

Business Development
$95,491 Avg. total comp.
+$11k
Finance
$84,288 Avg. total comp.
Operations
$76,859 Avg. total comp.
-$7k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to Novartis Oncology reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to Novartis Oncology reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.

How Financial Analysts at Novartis Oncology Rate Their Compensation

The majority of Financial Analysts at Novartis Oncology believe they're not compensated fairly. 100% of Financial Analysts at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company